期刊文献+

组织因子与产科凝血关系的初步研究 被引量:1

A primary study on the relationship between tissue factor and obstetrical coagulation
下载PDF
导出
摘要 目的检测正常足月妊娠胎盘、蜕膜和子宫肌层中是否富含在启动凝血、止血过程中起关键作用的组织因子(tissuefactor,TF),初步探讨TF与产科凝血间的关系。方法选择正常足月妊娠30例,用ELISA方法分别检测血浆、胎盘、蜕膜、子宫肌层中TF抗原含量。结果胎盘、蜕膜和子宫肌层中TF抗原含量分别为(35.43±1.51)ng/ml(14.17±0.60)ng/mg总蛋白、(39.00±1.88)ng/ml、(15.60±0.75)ng/mg总蛋白和(10.92±3.19)ng/ml(4.37±1.28)ng/mg总蛋白。血浆中为0.013ng/mg总蛋白。胎盘、蜕膜、子宫肌层的TF抗原含量分别是血浆的1090、1200、336倍。结论正常足月妊娠胎盘、蜕膜和子宫肌层富含TF,TF可能与胎盘剥离面凝血止血及产科凝血障碍有关。 Objective To explore the relationship between obstetrical coagulation and tissue factor (TF), the key component of the initiation of coagulation. Methods TF antigen was measured in serum, placenta, decidua and myometrium by immunoenzymatic method (ELISA) in 30 healthy pregnancy women. Results Concentrations of TF antigen in placenta, decidua and myometrium were (35.43±1.51) ng/ml (14. 17±0.60) ng/mg of total protein), (39. 005=1.88) ng/ml (15.60±0. 75) ng/mg of total protein) and (10.92±3.19) ng/ml (4.37±1.28) ng/mg of total protein), respectively. In serum, it was 0. 013 ng/mg of total protein. The levels of TF antigen in placenta, decidua and myometrium were 1 090 times, 1 200 times, 336 times higher than in blood. Conclusions Normal placenta, decidua and myometrium are significantly abundant of TF, which is closely related to coagulation. Therefore, obstetrical coagulation disturbances may be associated with abnormal TF at the surface of placenta separation.
出处 《中国妇产科临床杂志》 2006年第6期430-432,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 组织因子 胎盘 蜕膜 子宫肌层 产科凝血 tissue factor placenta decidua myometrium obstetrical coagulation
  • 相关文献

参考文献10

  • 1[1]Bazan JF.Structural design and molecular evolution of a cytokine receptor superfamily.Proc Natl Acad Sic USA,1990,87:6934-6938.
  • 2[2]Camerer E,Kolsto AB,Prydz H.Cell biology of tissue factor,the principal initiator of blood coagulation.Thromb Res,1996,81:1-41.
  • 3[3]Eilertsen KE,Osterud B.Tissue factor:(patho)physiology and cellular biology.Blood Coagul Fibrinolysis,2004,15:521-538.
  • 4[4]Levi M.The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis.Critical Care Medicine,2002,30:1914-1915.
  • 5[5]Phillips LL,Davidson EC.Procoagulant properties of amniotic fluid.Am J Obstet Gynecol,1972,113:911-919.
  • 6[6]Lockwood CHJ,Bach R,Guha A,et al.Amniotic fluid contains tissue factor,a potent initiator of coagulation.Am J Obstet Gynecol,1991,165(5 Pt1):1335-1341.
  • 7李少芬,刘燕儒,马海梅,张岩,张惠英.组织因子在足月妊娠羊水中的测定及临床分析[J].中华围产医学杂志,2002,5(3):183-185. 被引量:8
  • 8[8]Kuczynski J,Uszynski W,Zekanowska E,et al.Tissue factor(TF) and tissue factor pathway inhibitor (TFPI) in placenta and myometrium.Eur J Obstet Gynecol Reprod Biol,2002,105:15-19.
  • 9[9]Aharon A,Brenner B,Katz T,et al.Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells:implications for placental hemostasis.Thromb Haemost,2004,92:776-786.
  • 10[11]Imamura T,Sugiyama T,Cuevas LE,et al.Expression of tissue factor,the clotting initiator,on macrophages in Plasmodium falciparum-infected placentas.J Infect Dis,2002,186:436-440.

二级参考文献1

  • 1C. Fl?ssel,T. Luther,M. Müller,S. Albrecht,M. Kasper. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue[J] 1994,Histochemistry(6):449~453

共引文献7

同被引文献9

  • 1Chand HS,Foster DC,Kisiel W,et al.Structure function and biology of tissue factor pathway inhibitor-2[J].Thromb Haemost,2005,94:1122-1130.
  • 2Lwaleed BA,Bass PS.Tissue factor pathway inhibitor:structure,biology and involvement in disease[J].J Pathol,2006,208:327-339.
  • 3Sarig G,Blumenfeld Z,Leiba R,et al.Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss[J].Thromb Haemost,2005,94:980-985.
  • 4Abdel Gader AM,Al-Mishari AA,Awadalla SA,et al.Total and free tissue factor pathway inhibitor in pregnancy hypertension[J].Int J Gynaecol Obstet,2006,95:248-253.
  • 5Aharon A,Lanir N,Drugan A,et al.Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment[J].J Thromb Haemost,2005,3:2355-2357.
  • 6Teng YC,Lin QD,Lin JH,et al.Coagulation and fibrinolysis related cytokine imbalance in preeclampsia:the role of placental trophoblasts[J].J Perinat Med,2009,37:343-348.
  • 7Erze O,Espinoza J,Chatworapongsa T,et al.A link between a hemostatic disorder and preterm PROM:a role for tissue factor and tissue factor pathway inhibitor[J].J Matern Fetal Neonatal Med,2008,21:732-744.
  • 8Lockwood CJ,Paidas M,Murk WK.Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption[J].Thromb Res,2009,124:516-520.
  • 9Aharon A,Lanir N,Drugan A,et al.Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment[J].J Thromb Haemost,2005,3:2355-2357.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部